
Prioritize the right biological targets
Understanding disease pathogenesis and mechanisms requires information about biomarkers, proteins, biological pathways, and more. Gathering this disconnected data from disparate sources with inconsistent identifiers provides only a fragmented view into the biological processes at work. CAS BioFinder enhances your discovery biology research with the deeply connected data, visualizations, and tools you need to confidently identify the most promising targets.


Early discovery decisions ripple across your entire pipeline
Biologists set the direction of your drug program. Without clear biological context, your team risks advancing weak targets and missing opportunities, impacting timelines and costs. CAS BioFinder brings the information and tools needed to prioritize research paths, validate recommendations, and move forward confidently.
Curated literature that provides insights into biological relationships and interactions.
Interconnected data revealing associations between biomarkers, diseases, and pathways for clearer understanding of disease mechanisms.
Visualization tools that give pharmacological context to priority targets in early-stage research.

Make confident recommendations backed by dependable, interconnected data
From directing the team’s research paths to recommending targets for further investment, you need to be sure your decisions are based on clear, reliable information.
Because your team’s resources and reputation are at stake, CAS BioFinder structures, connects, and transforms biological evidence into actionable insights by combining the data and capabilities your team needs to bring clarity to early drug discovery.

Simplify antibody and peptide design
Unified sequence and structure data give you unmatched visibility into existing antibodies and peptides. Navigate quickly across relevant disease, target, ligand, and pharmacology data linked to literature and patent references.
Whether you innovate a new large molecule or select an existing one to deliver a small-molecule payload, CAS BioFinder helps you balance therapeutic outcomes with regulatory compliance and manufacturability.
CAS BioFinder advances discovery biology
Detailed biomarker tables, AI-generated biomarker summaries, filtering tools, and assay-linked references help biologists uncover disease mechanisms and identify key indicators for pathogenesis.
Button TextIdentify potential new targets and explore early signals of therapeutic potential with protein summaries, interactive 3D crystal structures, and detailed pathway diagrams that reveal biological function and therapeutic relevance.
Button TextConfirm a target’s therapeutic value by exploring ligand-disease-target combinations by selectivity, potency, and toxicity predictions, and reviewing linked assay and pathway data.
Button TextHarness drug intelligence dashboards, off-target interaction maps, and clinical trial links to uncover new indications and repurposing opportunities.
Button TextStay up to date with the latest in life sciences data, technology, breakthroughs, and more.
Related articles

How do predictive models empower drug discovery?

Innovations in cancer immunotherapy: Bi-specific T cell engagers
